These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8742802)

  • 21. Structure-activity relationships of the classic hallucinogens and their analogs.
    Jacob P; Shulgin AT
    NIDA Res Monogr; 1994; 146():74-91. PubMed ID: 8742795
    [No Abstract]   [Full Text] [Related]  

  • 22. [What takes place in the receptor? Ligand-receptor interaction in 5-HT agonists].
    Gurrath M
    Pharm Unserer Zeit; 2002; 31(5):470-8. PubMed ID: 12369165
    [No Abstract]   [Full Text] [Related]  

  • 23. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
    Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
    J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, molecular structure and expression of two cloned serotonin receptors from the pond snail, Helisoma trivolvis.
    Mapara S; Parries S; Quarrington C; Ahn KC; Gallin WJ; Goldberg JI
    J Exp Biol; 2008 Mar; 211(Pt 6):900-10. PubMed ID: 18310116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of some centrally acting drugs on caeruloplasmin.
    Barrass BC; Coult DB
    Prog Brain Res; 1972; 36():97-104. PubMed ID: 4644035
    [No Abstract]   [Full Text] [Related]  

  • 28. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
    Glennon RA
    J Med Chem; 2003 Jul; 46(14):2795-812. PubMed ID: 12825922
    [No Abstract]   [Full Text] [Related]  

  • 29. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
    Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
    Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization.
    Gray JA; Compton-Toth BA; Roth BL
    Biochemistry; 2003 Sep; 42(36):10853-62. PubMed ID: 12962510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor regulatory properties evident in the molecular similarity of serotonin receptor ligands and purine nucleotides.
    Williams WR; Pugh WJ; Nicholls PJ
    J Pharm Pharmacol; 2004 Dec; 56(12):1563-72. PubMed ID: 15563764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC; Arnold JC; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional reconstitution of the human serotonin receptor 5-HT(6) using synthetic transmembrane peptides.
    Lee WK; Han JJ; Jin BS; Boo DW; Yu YG
    Biochem Biophys Res Commun; 2009 Dec; 390(3):815-20. PubMed ID: 19836355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
    Clare BW
    J Med Chem; 1998 Sep; 41(20):3845-56. PubMed ID: 9748359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dynamics simulation of the heterodimeric mGluR2/5HT(2A) complex. An atomistic resolution study of a potential new target in psychiatric conditions.
    Bruno A; Guadix AE; Costantino G
    J Chem Inf Model; 2009 Jun; 49(6):1602-16. PubMed ID: 19422244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of drug discrimination in drug abuse research.
    Appel JB; Baker LE; Barrett RL; Broadbent J; Michael EM; Riddle EE; Van Groll BJ
    NIDA Res Monogr; 1991; (116):369-97. PubMed ID: 1369679
    [No Abstract]   [Full Text] [Related]  

  • 37. Allosteric modulation of 5-HT3 receptors: focus on alcohols and anaesthetic agents.
    Parker RM; Bentley KR; Barnes NM
    Trends Pharmacol Sci; 1996 Mar; 17(3):95-9. PubMed ID: 8936343
    [No Abstract]   [Full Text] [Related]  

  • 38. The indole hallucinogens--a new look at their mechanisms of action.
    Psychopharmacol Bull; 1982 Jul; 18(3):168-83. PubMed ID: 6292987
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin-based therapeutics.
    Higgins GA; Fletcher PJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):531-2. PubMed ID: 11888545
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-methoxy-alpha-methyltryptamine (alphs, o-dimethylserotonin), a hallucinogenic homolog of serotonin.
    Kantor RE; Dudlettes SD; Shulgin AT
    Biol Psychiatry; 1980 Apr; 15(2):349-52. PubMed ID: 7417623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.